宫癌中炎症相关免疫的新生物标志物
Weihong Zhao1, Qi Li1,2, Songquan Wen1,2
1Department of Obstetrics and Gynecology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Frontiers in oncology
|March 27, 2024
概括
这项研究确定了宫癌 (CC) 中的五个关键炎症和免疫相关基因. 这些生物标志物为改善这种妇科恶性瘤的早期诊断和治疗策略提供了潜力.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物信息学是一种生物信息学.
背景情况:
- 宫癌 (CC) 是一种严重的妇科恶性瘤,与持续高风险的人类乳头瘤病毒 (HPV) 感染和炎症密切相关.
- 早期检测和治疗的挑战需要识别CC的新型炎症相关免疫生物标志物.
研究的目的:
- 识别和验证宫癌的与炎症相关的免疫生物标志物.
- 探索早期诊断和CC的治疗干预的潜在目标.
主要方法:
- 整合了两个CC数据集 (GSE39001,GSE63514) 使用生物信息学去除批量效应.
- 使用R语言识别了与免疫相关的差异表达基因 (DGE).
- 进行了权重基因共同表达网络分析 (WGCNA),并构建了一个蛋白质-蛋白质相互作用网络.
主要成果:
- 确定了37种与炎症相关的DEG和15种与炎症相关的免疫DEG.
- 在CC中发现了七个与免疫透相关的模块.
- 选了五个枢纽基因 (CXCL8,CXCL10,CX3CR1,FCGR3B,SELL),并通过PCR验证了它们的表达,评估了诊断价值和免疫细胞关联.
结论:
- 在宫癌中确定了五种关键的炎症和免疫相关基因.
- 这些基因为改善CC的早期诊断和治疗提供了新的途径.
- 调查结果为解决CC管理提供了多视角的方法.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


